Vimarsana
Biggest News Aggregation in the World

Page 17 - Data Innovations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Innovations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Innovations Today - Breaking & Trending Today

Roper Technologies (NYSE:ROP) Releases Earnings Results, Beats Estimates By $0.05 EPS - Vimarsana News

Roper Technologies (NYSE:ROP) Releases Earnings Results, Beats Estimates By $0.05 EPS

Roper Technologies (NYSE:ROP – Get Rating) issued its quarterly earnings results on Thursday. The industrial products company reported $3.90 earnings per share for the quarter, topping analysts’ consensus estimates of $3.85 by $0.05, Briefing.com reports. Roper Technologies had a return on equity of 11.43% and a net margin of 80.89%. The firm had revenue of […]

Roper Technologies (NYSE:ROP) Updates Q2 Earnings Guidance - Vimarsana News

Roper Technologies (NYSE:ROP) Updates Q2 Earnings Guidance

Roper Technologies (NYSE:ROP – Get Rating) issued an update on its second quarter earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $3.96-4.00 for the period, compared to the consensus estimate of $3.96. Roper Technologies also updated its FY 2023 guidance to $16.10-$16.30 EPS. Analysts Set New Price Targets A […]

Source: wkrb13.com
Roper Technologies (NYSE:ROP) Releases Q2 2023 Earnings Guidance - Vimarsana News

Roper Technologies (NYSE:ROP) Releases Q2 2023 Earnings Guidance

Roper Technologies (NYSE:ROP – Get Rating) updated its second quarter 2023 earnings guidance on Thursday. The company provided EPS guidance of $3.96-$4.00 for the period, compared to the consensus EPS estimate of $3.96. The company issued revenue guidance of -. Roper Technologies also updated its FY 2023 guidance to $16.10-$16.30 EPS. Analysts Set New Price […]

Source: wkrb13.com
Short Interest in Summit Therapeutics Inc. (NASDAQ:SMMT) Rises By 18.6% - Vimarsana News

Short Interest in Summit Therapeutics Inc. (NASDAQ:SMMT) Rises By 18.6%

Should You Buy or Sell Roper Technologies Stock? Get The Latest ROP Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.

Roper Technologies (NYSE:ROP) Releases FY 2023 Earnings Guidance - Vimarsana News

Roper Technologies (NYSE:ROP) Releases FY 2023 Earnings Guidance

Roper Technologies (NYSE:ROP – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $16.10-$16.30 for the period, compared to the consensus estimate of $16.17. The company issued revenue guidance of -. Roper Technologies also updated its FY23 guidance to $16.10-16.30 EPS. […]